Heart Rate Response to Regadenoson and Sudden Cardiac Death

Trial Profile

Heart Rate Response to Regadenoson and Sudden Cardiac Death

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Mar 2017

At a glance

  • Drugs Regadenoson (Primary)
  • Indications Coronary disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Mar 2017 Planned Primary Completion date has been changed from 2 Feb 2017 to 1 Dec 2018.
    • 17 Mar 2017 Planned End date has been changed from 2 Feb 2017 to 1 Dec 2018.
    • 15 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top